Reducing stillbirths: screening and monitoring during pregnancy and labour

Rachel A Haws, Mohammad Yawar Yakoob, Tanya Soomro, Esme V Menezes, Gary L Darmstadt, Zulfiqar A Bhutta, Rachel A Haws, Mohammad Yawar Yakoob, Tanya Soomro, Esme V Menezes, Gary L Darmstadt, Zulfiqar A Bhutta

Abstract

Background: Screening and monitoring in pregnancy are strategies used by healthcare providers to identify high-risk pregnancies so that they can provide more targeted and appropriate treatment and follow-up care, and to monitor fetal well-being in both low- and high-risk pregnancies. The use of many of these techniques is controversial and their ability to detect fetal compromise often unknown. Theoretically, appropriate management of maternal and fetal risk factors and complications that are detected in pregnancy and labour could prevent a large proportion of the world's 3.2 million estimated annual stillbirths, as well as minimise maternal and neonatal morbidity and mortality.

Methods: The fourth in a series of papers assessing the evidence base for prevention of stillbirths, this paper reviews available published evidence for the impact of 14 screening and monitoring interventions in pregnancy on stillbirth, including identification and management of high-risk pregnancies, advanced monitoring techniques, and monitoring of labour. Using broad and specific strategies to search PubMed and the Cochrane Library, we identified 221 relevant reviews and studies testing screening and monitoring interventions during the antenatal and intrapartum periods and reporting stillbirth or perinatal mortality as an outcome.

Results: We found a dearth of rigorous evidence of direct impact of any of these screening procedures and interventions on stillbirth incidence. Observational studies testing some interventions, including fetal movement monitoring and Doppler monitoring, showed some evidence of impact on stillbirths in selected high-risk populations, but require larger rigourous trials to confirm impact. Other interventions, such as amniotic fluid assessment for oligohydramnios, appear predictive of stillbirth risk, but studies are lacking which assess the impact on perinatal mortality of subsequent intervention based on test findings. Few rigorous studies of cardiotocography have reported stillbirth outcomes, but steep declines in stillbirth rates have been observed in high-income settings such as the U.S., where cardiotocography is used in conjunction with Caesarean section for fetal distress.

Conclusion: There are numerous research gaps and large, adequately controlled trials are still needed for most of the interventions we considered. The impact of monitoring interventions on stillbirth relies on use of effective and timely intervention should problems be detected. Numerous studies indicated that positive tests were associated with increased perinatal mortality, but while some tests had good sensitivity in detecting distress, false-positive rates were high for most tests, and questions remain about optimal timing, frequency, and implications of testing. Few studies included assessments of impact of subsequent intervention needed before recommending particular monitoring strategies as a means to decrease stillbirth incidence. In high-income countries such as the US, observational evidence suggests that widespread use of cardiotocography with Caesarean section for fetal distress has led to significant declines in stillbirth rates. Efforts to increase availability of Caesarean section in low-/middle-income countries should be coupled with intrapartum monitoring technologies where resources and provider skills permit.

Figures

Figure 1
Figure 1
Forest plot of results of meta-analysis of perinatal mortality rates in women examined by routine vs. selective ultrasound in early pregnancy.
Figure 2
Figure 2
Meta-analysis (Forest plot, Fixed effects model) of impact of vibroacoustic stimulation versus mock or no stimulation on intrauterine or perinatal deaths.
Figure 3
Figure 3
Meta-analysis (Forest plot, Random effects model) of impact of vibroacoustic stimulation versus mock or no stimulation on intrauterine or perinatal deaths.

References

    1. Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database Syst Rev. 2008:CD000038.
    1. Alfirevic Z, Devane D, Gyte GM. Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour. Cochrane Database Syst Rev. 2006;3:CD006066.
    1. Katz M, Meizner I, Insler V. Fetal Well-being: Physiological Basis and Methods of Clinical Assessment. CRC Press; 1990.
    1. Lawn JE, Yakoob MY, Haws RA, Soomro T, Darmstadt GL, Bhutta ZA. 3.2 million stillbirths: epidemiology and overview of the evidence review. BMC Pregnancy and Childbirth. 2009;9:S2.
    1. Coopland AT, Peddle LJ, Baskett TF, Rollwagen R, Simpson A, Parker E. A simplified antepartum high-risk pregnancy scoring form: statistical analysis of 5459 cases. Can Med Assoc J. 1977;116:999–1001.
    1. Hobel CJ, Hyvarinen MA, Okada DM, Oh W. Prenatal and intrapartum high-risk screening. I. Prediction of the high-risk neonate. Am J Obstet Gynecol. 1973;117:1–9.
    1. Lilford RJ, Chard T. Problems and pitfalls of risk assessment in antenatal care. Br J Obstet Gynaecol. 1983;90:507–510.
    1. Pattison NS, Sadler L, Mullins P. Obstetric risk factors: can they predict fetal mortality and morbidity? N Z Med J. 1990;103:257–259.
    1. Knox AJ, Sadler L, Pattison NS, Mantell CD, Mullins P. An obstetric scoring system: its development and application in obstetric management. Obstet Gynecol. 1993;81:195–199.
    1. Chard T, Learmont J, Carroll S, Hudson C, Lloyd DS, Sloan D. Evaluation of a fetal risk-scoring system. Am J Perinatol. 1992;9:388–393. doi: 10.1055/s-2007-999272.
    1. Morrison I, Olsen J. Perinatal mortality and antepartum risk scoring. Obstet Gynecol. 1979;53:362–366.
    1. Majoko F, Nystrom L, Munjanja S, Lindmark G. Usefulness of risk scoring at booking for antenatal care in predicting adverse pregnancy outcome in a rural African setting. J Obstet Gynaecol. 2002;22:604–609. doi: 10.1080/0144361021000020358.
    1. Talsania NJ, Lala MK. Scoring of high risk pregnant women and related outcome. Indian J Matern Child Health. 1991;2:92–94.
    1. Talsania NJ, Lala MK. Evaluation of antenatal risk scoring in a preterm birth prevention and perinatal loss. Indian J Matern Child Health. 1994;5:5–9.
    1. LeFevre M, Williamson HA, Hector M., Jr Obstetric risk assessment in rural practice. J Fam Pract. 1989;28:691–695. discussion 695–696.
    1. Humphrey MD. The beneficial use of risk scoring in a remote and high-risk pregnant population. J Perinat Med. 1990;18:23–29.
    1. de Caunes F, Alexander GR, Berchel C, Guengant JP, Papiernik E. Anamnestic pregnancy risk assessment. Int J Gynaecol Obstet. 1990;33:221–227. doi: 10.1016/0020-7292(90)90005-6.
    1. Abraham S, Joshi S, Kumar V, Patwary A, Pratinidhi A, Saxena VB, Maitra K, Singh KK, Saxena NC, Saxena BN. Indian experience of home based mothers' card: ICMR task force study. Indian J Pediatr. 1991;58:795–804. doi: 10.1007/BF02825437.
    1. Wall EM. Assessing obstetric risk. A review of obstetric risk-scoring systems. J Fam Pract. 1988;27:153–163.
    1. Velazquez MD, Rayburn WF. Antenatal evaluation of the fetus using fetal movement monitoring. Clin Obstet Gynecol. 2002;45:993–1004. doi: 10.1097/00003081-200212000-00006.
    1. Boehm FH, Gabbe SG. Putting it all together. Clin Obstet Gynecol. 2002;45:1063–1068. doi: 10.1097/00003081-200212000-00012.
    1. Mangesi L, Hofmeyr GJ. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews. 2007;1:CD004909.
    1. Lema VM, Rogo KO, Mwalali PN. Fetal movements: value in monitoring high-risk pregnancies. East Afr Med J. 1988;65:785–792.
    1. De Muylder X. The kick chart in high-risk pregnancies: a two-year experience in Zimbabwe. Int J Gynaecol Obstet. 1988;27:353–357. doi: 10.1016/0020-7292(88)90112-9.
    1. Sinha D, Sharma A, Nallaswamy V, Jayagopal N, Bhatti N. Obstetric outcome in women complaining of reduced fetal movements. J Obstet Gynaecol. 2007;27:41–43. doi: 10.1080/01443610601016909.
    1. Romero Gutierrez G, Sanchez Cortes R, Soto Pompa V, Rodriguez Flores P. [Perinatal morbidity and mortality associated with fetal hypomotility] Ginecol Obstet Mex. 1994;62:222–225.
    1. Moore TR, Piacquadio K. A prospective evaluation of fetal movement screening to reduce the incidence of antepartum fetal death. Am J Obstet Gynecol. 1989;160:1075–1080.
    1. Grant A, Elbourne D, Valentin L, Alexander S. Routine formal fetal movement counting and risks of antepartum late deaths in nomally formed singletons. Lancet. 1989;2:345–347. doi: 10.1016/S0140-6736(89)90535-7.
    1. National Institute for Health and Clinical Excellence CG62: Antenatal care – Routine care for the healthy pregnant woman, full guideline. 2008. (accessed 31 Jan 2009)
    1. Del Mar C, O'Connor V. Should we stop telling well pregnant women to monitor fetal movements? How to use and interpret guidelines. Br J Gen Pract. 2004;54:810.
    1. Neilson J. Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews. 1998. p. CD000182.
    1. Mahran M, Omran M. The impact of diagnostic ultrasound on the prediction of intrauterine growth retardation in developing countries. Int J Gynaecol Obstet. 1988;26:375–378. doi: 10.1016/0020-7292(88)90332-3.
    1. Whitworth M, Bricker L, Neilson JP. Ultrasound for fetalassessment in early pregnancy (Protocol) Cochrane Database of Systematic Reviews. 2008;1:CD007058.
    1. Bricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks' gestation) Cochrane Database Syst Rev. 2008:CD001451.
    1. Duff GB. A randomized controlled trial in a hospital population of ultrasound measurement screening for the small for dates baby. Aust N Z J Obstet Gynaecol. 1993;33:374–378. doi: 10.1111/j.1479-828X.1993.tb02113.x.
    1. Proud J, Grant AM. Third trimester placental grading by ultrasonography as a test of fetal wellbeing. Br Med J (Clin Res Ed) 1987;294:1641–1644. doi: 10.1136/bmj.294.6588.1641.
    1. Rouse DJ, Owen J, Goldenberg RL, Cliver SP. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA. 1996;276:1480–1486. doi: 10.1001/jama.276.18.1480.
    1. Reddy UM, Filly RA, Copel JA. Prenatal imaging: ultrasonography and magnetic resonance imaging. Obstet Gynecol. 2008;112:145–157.
    1. Papageorghiou AT, Leslie K. Uterine artery Doppler in the prediction of adverse pregnancy outcome. Curr Opin Obstet Gynecol. 2007;19:103–109.
    1. FitzGerald DE, Drumm JE. Non-invasive measurement of human fetal circulation using ultrasound: a new method. Br Med J. 1977;2:1450–1451. doi: 10.1136/bmj.2.6100.1450.
    1. Theron GB, Pattinson RC. Management of patients with poor symphysis pubis-fundus growth by Doppler flow velocimetry of the umbilical artery – an effective method to detect the fetus at risk. Int J Gynaecol Obstet. 1992;39:93–98. doi: 10.1016/0020-7292(92)90903-V.
    1. Torres PJ, Gratacos E, Alonso PL. Umbilical artery Doppler ultrasound predicts low birth weight and fetal death in hypertensive pregnancies. Acta Obstet Gynecol Scand. 1995;74:352–355. doi: 10.3109/00016349509024427.
    1. Turan OM, Turan S, Gungor S, Berg C, Moyano D, Gembruch U, Nicolaides KH, Harman CR, Baschat AA. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;32:160–167. doi: 10.1002/uog.5386.
    1. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med. 2002;12:78–88. doi: 10.1080/713605620.
    1. Smith GC, Yu CK, Papageorghiou AT, Cacho AM, Nicolaides KH. Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol. 2007;109:144–151.
    1. Subtil D, Goeusse P, Houfflin-Debarge V, Puech F, Lequien P, Breart G, Uzan S, Quandalle F, Delcourt YM, Malek YM. Randomised comparison of uterine artery Doppler and aspirin (100 mg) with placebo in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 2) BJOG. 2003;110:485–491.
    1. Baschat AA, Gembruch U, Weiner CP, Harman CR. Qualitative venous Doppler waveform analysis improves prediction of critical perinatal outcomes in premature growth-restricted fetuses. Ultrasound Obstet Gynecol. 2003;22:240–245. doi: 10.1002/uog.149.
    1. Hugo EJ, Odendaal HJ, Grove D. Evaluation of the use of umbilical artery Doppler flow studies and outcome of pregnancies at a secondary hospital. J Matern Fetal Neonatal Med. 2007;20:233–239. doi: 10.1080/14767050601134926.
    1. Baschat AA. Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction. Ultrasound Obstet Gynecol. 2004;23:111–118. doi: 10.1002/uog.989.
    1. Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews. 1996. p. CD000073.
    1. Alfirevic Z, Stampalija T, Gyte GML, Neilson JP. Fetal and umbilical Doppler ultrasound in high-risk pregnancies (Protocol) Cochrane Database of Systematic Reviews. 2009. p. CD007529.
    1. Giles W, Bisits A, O'Callaghan S, Gill A. The Doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery Doppler ultrasound and biometry in twin pregnancy. BJOG. 2003;110:593–597. doi: 10.1046/j.1471-0528.2003.02066.x.
    1. Divon MY, Ferber A. Doppler evaluation of the fetus. Clin Obstet Gynecol. 2002;45:1015–1025. doi: 10.1097/00003081-200212000-00008.
    1. Lees C, Baumgartner H. The TRUFFLE study – a collaborative publicly funded project from concept to reality: how to negotiate an ethical, administrative and funding obstacle course in the European Union. Ultrasound Obstet Gynecol. 2005;25:105–107. doi: 10.1002/uog.1836.
    1. Fine EA, Bracken M, Berkowitz RL. An evaluation of the usefulness of x-ray pelvimetry: comparison of the Thoms and modified Ball methods with manual pelvimetry. Am J Obstet Gynecol. 1980;137:15–20.
    1. Pattinson RC, Farrell E. Pelvimetry for fetal cephalic presentations at or near term. Cochrane Database of Systematic Reviews. 1997. p. CD000161.
    1. Parsons MT, Spellacy WN. Prospective randomized study of x-ray pelvimetry in the primigravida. Obstet Gynecol. 1985;66:76–79.
    1. Crichton D. The accuracy and value of cephalopelvimetry. Journal of Obstetrics and Gynaecology of the British Commonwealth. 1962;69:366–378.
    1. Richards A, Strang A, Moodley J, Philpott H. Vaginal delivery following caesarean section – is X-ray pelvimetry a reliable predictor? Proceedings of 4th Conference on Priorities in Perinatal Care in South Africa: 1985; Natal, South Africa. 1985. pp. 62–65.
    1. Macintosh MC, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, Golightly S, Miller A. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ. 2006;333:177. doi: 10.1136/.
    1. Enkin M, Keirse MJNC, Neilson J, Crowther C, Duley L, Hodnett E, Hofmeyr GJ, editors . A guide to effective care in pregnancy and childbirth. 3. Oxford: Oxford University Press; 2000.
    1. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ. 1997;315:275–278.
    1. Jarrett RJ, Castro-Soares J, Dornhorst A, Beard RW. Should we screen for gestational diabetes? BMJ. 1997;315:736–739.
    1. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin Ther. 2007;29:S153–160. doi: 10.1016/j.clinthera.2007.12.015.
    1. Delgado Del Rey M, Herranz L, Martin Vaquero P, Janez M, Juan Lozano Garcia J, Darias R, Felipe Pallardo L. [Effect of preconceptional metabolic control in the course of pregnancy in diabetic patients] Med Clin (Barc) 2001;117:45–48.
    1. Darias R, Herranz L, Garcia-Ingelmo MT, Pallardo LF. Pregnancy in a patient with type 1 diabetes mellitus and prior ischaemic heart disease. Eur J Endocrinol. 2001;144:309–310. doi: 10.1530/eje.0.1440309.
    1. Russell MA, Carpenter MW, Coustan DR. Screening and diagnosis of gestational diabetes mellitus. Clin Obstet Gynecol. 2007;50:949–958. doi: 10.1097/GRF.0b013e31815a5510.
    1. Broughton Pipkin F. Risk factors for preeclampsia. N Engl J Med. 2001;344:925–926. doi: 10.1056/NEJM200103223441209.
    1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–553. doi: 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>;2-S.
    1. Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30:S251–260. doi: 10.2337/dc07-s225.
    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;29:S43–48.
    1. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes. Obstet Gynecol. 2001;98:525–538.
    1. Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev. 2003:CD003395.
    1. Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 1994;170:1036–1046. discussion 1046-1037.
    1. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–2486. doi: 10.1056/NEJMoa042973.
    1. Gonzalez-Quintero VH, Istwan NB, Rhea DJ, Rodriguez LI, Cotter A, Carter J, Mueller A, Stanziano GJ. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care. 2007;30:467–470. doi: 10.2337/dc06-1875.
    1. Banerjee S, Ghosh US, Banerjee D. Effect of tight glycaemic control on fetal complications in diabetic pregnancies. J Assoc Physicians India. 2004;52:109–113.
    1. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddiqi T, Dignan PS, Tsang RC. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000;9:14–20. doi: 10.1002/(SICI)1520-6661(200001/02)9:1<14::AID-MFM5>;2-K.
    1. Huddle KR. Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992 – 2002. S Afr Med J. 2005;95:789–794.
    1. Landon MB, Langer O, Gabbe SG, Schick C, Brustman L. Fetal surveillance in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol. 1992;167:617–621.
    1. Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol. 2007;197:447–456. doi: 10.1016/j.ajog.2007.03.062.
    1. Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol. 2008;198:186. doi: 10.1016/j.ajog.2007.08.005. e181-187.
    1. Aucott SW, Williams TG, Hertz RH, Kalhan SC. Rigorous management of insulin-dependent diabetes mellitus during pregnancy. Acta Diabetol. 1994;31:126–129. doi: 10.1007/BF00570364.
    1. Boulvain M, Stan C, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database Syst Rev. 2001:CD001997.
    1. Dudley DJ. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Clin Perinatol. 2007;34:611–626. doi: 10.1016/j.clp.2007.09.003.
    1. O'Sullivan JB, Charles D, Mahan CM, Dandrow RV. Gestational diabetes and perinatal mortality rate. Am J Obstet Gynecol. 1973;116:901–904.
    1. Solt I, Divon MY. Fetal surveillance tests. In: Blazer S, Zimmer EZ, editor. The Embryo: Scientific Discovery and Medical Ethics. Basel: Karger; 2005. pp. 291–308.
    1. Flynn AM, Kelly J, Mansfield H, Needham P, O'Conor M, Viegas O. A randomized controlled trial of non-stress antepartum cardiotocography. Br J Obstet Gynaecol. 1982;89:427–433.
    1. Rayburn W, Greene J, Jr, Donaldson M. Nonstress testing and perinatal outcome. J Reprod Med. 1980;24:191–196.
    1. Evertson LR, Gauthier RJ, Collea JV. Fetal demise following negative contraction stress tests. Obstet Gynecol. 1978;51:671–673.
    1. Pattison N, McCowan L. Cardiotocography for antepartum fetal assessment. Cochrane Database of Systematic Reviews. 1999. p. CD001068.
    1. Freeman RK, Anderson G, Dorchester W. A prospective multi-institutional study of antepartum fetal heart rate monitoring. II. Contraction stress test versus nonstress test for primary surveillance. Am J Obstet Gynecol. 1982;143:778–781.
    1. Manning FA, Lange IR, Morrison I, Harman CR. Fetal biophysical profile score and the nonstress test: a comparative trial. Obstet Gynecol. 1984;64:326–331.
    1. Freeman RK, Anderson G, Dorchester W. A prospective multi-institutional study of antepartum fetal heart rate monitoring. I. Risk of perinatal mortality and morbidity according to antepartum fetal heart rate test results. Am J Obstet Gynecol. 1982;143:771–777.
    1. de la Vega A, Verdiales M. Failure of intensive fetal monitoring and ultrasound in reducing the stillbirth rate. P R Health Sci J. 2002;21:123–125.
    1. Kennelly MM, Sturgiss SN. Management of small-for-gestational-age twins with absent/reversed end diastolic flow in the umbilical artery: outcome of a policy of daily biophysical profile (BPP) Prenat Diagn. 2007;27:77–80. doi: 10.1002/pd.1630.
    1. Golde SH, Montoro M, Good-Anderson B, Broussard P, Jacobs N, Loesser C, Trujillo M, Walla C, Phelan J, Platt LD. The role of nonstress tests, fetal biophysical profile, and contraction stress tests in the outpatient management of insulin-requiring diabetic pregnancies. Am J Obstet Gynecol. 1984;148:269–273.
    1. Nageotte MP, Towers CV, Asrat T, Freeman RK. Perinatal outcome with the modified biophysical profile. Am J Obstet Gynecol. 1994;170:1672–1676.
    1. Manning FA. Fetal biophysical profile. Obstet Gynecol Clin North Am. 1999;26:557–577. doi: 10.1016/S0889-8545(05)70099-1.
    1. Tongprasert F, Jinpala S, Srisupandit K, Tongsong T. The rapid biophysical profile for early intrapartum fetal well-being assessment. Int J Gynaecol Obstet. 2006;95:14–17. doi: 10.1016/j.ijgo.2006.05.015.
    1. Awad MM. The fetal biophysical profile score: a routine screening technique for pregnant women. J Egypt Soc Obstet Gynecol. 1991;17:27–32.
    1. Tan KH, Smyth R. Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing. Cochrane Database Syst Rev. 2001:CD002963.
    1. Papadopoulos VG, Decavalas GO, Kondakis XG, Beratis NG. Vibroacoustic stimulation in abnormal biophysical profile: verification of facilitation of fetal well-being. Early Hum Dev. 2007;83:191–197. doi: 10.1016/j.earlhumdev.2006.05.014.
    1. Sood A. Vibroacoustic stimulation and modified fetal biophysical profile in high risk pregnancy. Journal of Obstetrics and Gynaecology of India. 2007;57:27–36.
    1. Harman CR. Amniotic fluid abnormalities. Semin Perinatol. 2008;32:288–294. doi: 10.1053/j.semperi.2008.04.012.
    1. Flack NJ, Fisk NM. Oligohydramnios and associated fetal complications. Fetal and Maternal Medicine Review. Vol. 5. Cambridge University Press; 1993.
    1. Magann EF, Chauhan SP, Doherty DA, Lutgendorf MA, Magann MI, Morrison JC. A review of idiopathic hydramnios and pregnancy outcomes. Obstet Gynecol Surv. 2007;62:795–802. doi: 10.1097/01.ogx.0000290349.58707.e0.
    1. Ventolini G, Neiger R. Placental dysfunction: pathophysiology and clinical considerations. J Obstet Gynaecol. 2006;26:728–730. doi: 10.1080/01443610600955685.
    1. Stoll CG, Roth MP, Dott B, Alembik Y. Study of 290 cases of polyhydramnios and congenital malformations in a series of 225,669 consecutive births. Community Genet. 1999;2:36–42. doi: 10.1159/000016182.
    1. Phelan JP, Park YW, Ahn MO, Rutherford SE. Polyhydramnios and perinatal outcome. J Perinatol. 1990;10:347–350.
    1. Magann EF, Isler CM, Chauhan SP, Martin JN., Jr Amniotic fluid volume estimation and the biophysical profile: a confusion of criteria. Obstet Gynecol. 2000;96:640–642. doi: 10.1016/S0029-7844(99)00634-1.
    1. Mazor M, Ghezzi F, Maymon E, Shoham-Vardi I, Vardi H, Hershkowitz R, Leiberman JR. Polyhydramnios is an independent risk factor for perinatal mortality and intrapartum morbidity in preterm delivery. Eur J Obstet Gynecol Reprod Biol. 1996;70:41–47. doi: 10.1016/S0301-2115(96)02551-1.
    1. Dashe JS, McIntire DD, Ramus RM, Santos-Ramos R, Twickler DM. Hydramnios: anomaly prevalence and sonographic detection. Obstet Gynecol. 2002;100:134–139. doi: 10.1016/S0029-7844(02)02013-6.
    1. Erez O, Shoham-Vardi I, Sheiner E, Dukler D, Bashiri A, Mazor M. Hydramnios and small for gestational age are independent risk factors for neonatal mortality and maternal morbidity. Arch Gynecol Obstet. 2005;271:296–301. doi: 10.1007/s00404-004-0656-4.
    1. Anandakumar C, Biswas A, Arulkumaran S, Wong YC, Malarvishy G, Ratnam SS. Should assessment of amniotic fluid volume form an integral part of antenatal fetal surveillance of high risk pregnancy? Aust N Z J Obstet Gynaecol. 1993;33:272–275. doi: 10.1111/j.1479-828X.1993.tb02084.x.
    1. Locatelli A, Zagarella A, Toso L, Assi F, Ghidini A, Biffi A. Serial assessment of amniotic fluid index in uncomplicated term pregnancies: prognostic value of amniotic fluid reduction. J Matern Fetal Neonatal Med. 2004;15:233–236. doi: 10.1080/14767050410001668671.
    1. Baron C, Morgan MA, Garite TJ. The impact of amniotic fluid volume assessed intrapartum on perinatal outcome. Am J Obstet Gynecol. 1995;173:167–174. doi: 10.1016/0002-9378(95)90185-X.
    1. Myles TD, Strassner HT. Four-quadrant assessment of amniotic fluid volume: distribution's role in predicting fetal outcome. Obstet Gynecol. 1992;80:769–774.
    1. Youssef AA, Abdulla SA, Sayed EH, Salem HT, Abdelalim AM, Devoe LD. Superiority of amniotic fluid index over amniotic fluid pocket measurement for predicting bad fetal outcome. South Med J. 1993;86:426–429. doi: 10.1097/00007611-199304000-00011.
    1. Morris JM, Thompson K, Smithey J, Gaffney G, Cooke I, Chamberlain P, Hope P, Altman D, MacKenzie IZ. The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study. BJOG. 2003;110:989–994. doi: 10.1111/j.1471-0528.2003.02417.x.
    1. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database of Systematic Reviews. 2007. p. CD006593.
    1. Williams K, Wittmann B, Dansereau J. Intraobserver reliability of amniotic fluid volume estimation by two techniques: amniotic fluid index vs. maximum vertical pocket. Ultrasound Obstet Gynecol. 1993;3:346–349. doi: 10.1046/j.1469-0705.1993.03050346.x.
    1. Alfirevic Z, Luckas M, Walkinshaw SA, McFarlane M, Curran R. A randomised comparison between amniotic fluid index and maximum pool depth in the monitoring of post-term pregnancy. Br J Obstet Gynaecol. 1997;104:207–211.
    1. Oral B, Gocen C, Ozbasar D. A comparison between two different ultrasonographic methods for assessing amniotic fluid volume in postterm pregnancies. Ondokuz Mayis Universitesi Tip Dergisi. 1999;16:180–186.
    1. Chauhan SP, Washburne JF, Magann EF, Perry KG, Jr, Martin JN, Jr, Morrison JC. A randomized study to assess the efficacy of the amniotic fluid index as a fetal admission test. Obstet Gynecol. 1995;86:9–13. doi: 10.1016/0029-7844(95)00110-D.
    1. Hofmeyr GJ, Gulmezoglu AM. Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume. Cochrane Database Syst Rev. 2002:CD000134.
    1. Crowther CA. Hospitalisation and bed rest for multiple pregnancy. Cochrane Database Syst Rev. 2001:CD000110.
    1. Saunders MC, Dick JS, Brown IM, McPherson K, Chalmers I. The effects of hospital admission for bed rest on the duration of twin pregnancy: a randomised trial. Lancet. 1985;2:793–795. doi: 10.1016/S0140-6736(85)90792-5.
    1. Crowther CA, Verkuyl DA, Ashworth MF, Bannerman C, Ashurst HM. The effects of hospitalization for bed rest on duration of gestation, fetal growth and neonatal morbidity in triplet pregnancy. Acta Genet Med Gemellol (Roma) 1991;40:63–68.
    1. Meher S, Abalos E, Carroli G. Bed rest with or without hospitalisation for hypertension during pregnancy. Cochrane Database Syst Rev. 2005:CD003514.
    1. Monincx WM, Zondervan HA, Birnie E, Ris M, Bossuyt PM. High risk pregnancy monitored antenatally at home. Eur J Obstet Gynecol Reprod Biol. 1997;75:147–153. doi: 10.1016/S0301-2115(97)00122-X.
    1. [A method of evaluating self-monitoring at home during pregnancy] Zhonghua Fu Chan Ke Za Zhi. 1990;25:130–133.
    1. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol. 1992;99:13–17.
    1. Soothill PW, Ajayi R, Campbell S, Gibbs J, Chandran R, Gibb D, Nicolaides KH. Effect of a fetal surveillance unit on admission of antenatal patients to hospital. BMJ. 1991;303:269–271. doi: 10.1136/bmj.303.6797.269.
    1. Kroner C, Turnbull D, Wilkinson C. Antenatal day care units versus hospital admission for women with complicated pregnancy. Cochrane Database Syst Rev. 2001:CD001803.
    1. Tuffnell DJ, Lilford RJ, Buchan PC, Prendiville VM, Tuffnell AJ, Holgate MP, Jones MD. Randomised controlled trial of day care for hypertension in pregnancy. Lancet. 1992;339:224–227. doi: 10.1016/0140-6736(92)90017-W.
    1. Grivell RM, Wong L, Bhatia V. Regimens of fetal surveillance for impaired fetal growth (Protocol) Cochrane Database ofSystematic Reviews. 2008. p. CD007113.
    1. Menzies J, Magee LA, Li J, MacNab YC, Yin R, Stuart H, Baraty B, Lam E, Hamilton T, Lee SK, et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol. 2007;110:121–127.
    1. Lavender T, Malcolmson L. Is the partogram a help or a hindrance? An exploratory study of midwives' views. Pract Midwife. 1999;2:23–27.
    1. Lavender T, Hart A, Smyth RM. Effect of partogram use onoutcomes for women in spontaneous labour at term. Cochrane Database Syst Rev. 2008:CD005461.
    1. Walss Rodriguez RJ, Gudino Ruiz F, Tapia Rodriguez S. [Trial of labor. A comparative study between Friedman's partogram and the conventional descriptive partogram] Ginecol Obstet Mex. 1987;55:318–322.
    1. Windrim R, Seaward G, Hodnett E, Akoury H, Kingdom J, Salenieks ME, et al. A randomized controlled trial of a bedside partogram in the active management of primiparous labour. Journal of Obstetrics and Gynaecology Canada. 2006;29:27–34.
    1. Lavender T, Alfirevic Z, Walkinshaw S. Partogram action line study: a randomised trial. Br J Obstet Gynaecol. 1998;105:976–980.
    1. Lavender T, Alfirevic Z, Walkinshaw S. Effect of different partogram action lines on birth outcomes: a randomized controlled trial. Obstet Gynecol. 2006;108:295–302.
    1. Pattinson RC, Howarth GR, Mdluli W, Macdonald AP, Makin JD, Funk M. Aggressive or expectant management of labour: a randomised clinical trial. BJOG. 2003;110:457–461. doi: 10.1046/j.1471-0528.2003.02298.x.
    1. World Health Organization partograph in management of labour. World Health Organization Maternal Health and Safe Motherhood Programme. Lancet. 1994;343:1399–1404.
    1. Lennox C. Active management of labour. WHO partogram helps. BMJ. 1994;309:1016–1017.
    1. Fahdhy M, Chongsuvivatwong V. Evaluation of World Health Organization partograph implementation by midwives for maternity home birth in Medan, Indonesia. Midwifery. 2005;21:301–310. doi: 10.1016/j.midw.2004.12.010.
    1. East CE, Chan FY, Colditz PB, Begg LM. Fetal pulse oximetry for fetal assessment in labour. Cochrane Database Syst Rev. 2007:CD004075.
    1. Royal College of Obstetricians and Gynaecologists . The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. Evidence-based Clinical Guideline Number 8. London: RCOG Press; 2001.
    1. Colditz PB, Begg LM, East CE. Fetal pulse oximetry. Instrumentation and recent clinical experience. Clin Perinatol. 1999;26:869–880.
    1. Kuhnert M, Seelbach-Goebel B, Butterwegge M. Predictive agreement between the fetal arterial oxygen saturation and fetal scalp pH: results of the German multicenter study. Am J Obstet Gynecol. 1998;178:330–335. doi: 10.1016/S0002-9378(98)80021-5.
    1. Devane D, Lalor JG, Daly S, McGuire W. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. (Protocol) Cochrane Database of Systematic Reviews. 2005. p. CD005122.
    1. Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev. 2006;3:CD000116.
    1. Fretts RC, Boyd ME, Usher RH, Usher HA. The changing pattern of fetal death, 1961–1988. Obstet Gynecol. 1992;79:35–39.
    1. Smith J, Wells L, Dodd K. The continuing fall in incidence of hypoxic-ischaemic encephalopathy in term infants. BJOG. 2000;107:461–466. doi: 10.1111/j.1471-0528.2000.tb13262.x.
    1. Kalter H. Five-decade international trends in the relation of perinatal mortality and congenital malformations: stillbirth and neonatal death compared. Int J Epidemiol. 1991;20:173–179. doi: 10.1093/ije/20.1.173.
    1. Smith GC, Fretts RC. Stillbirth. Lancet. 2007;370:1715–1725. doi: 10.1016/S0140-6736(07)61723-1.
    1. Smith GC, Crossley JA, Aitken DA, Pell JP, Cameron AD, Connor JM, Dobbie R. First Trimester Placentation and Risk of Antepartum Stillbirth. JAMA. 2004;292:2249–2254. doi: 10.1001/jama.292.18.2249.
    1. Stanton C, Lawn JE, Rahman H, Wilczynska-Ketende K, Hill K. Stillbirth rates: delivering estimates in 190 countries. The Lancet. 2006;367:1487–1494. doi: 10.1016/S0140-6736(06)68586-3.
    1. Grivell RM, Wong L, Bhatia V. Regimens of fetal surveillance for impaired fetal growth. Cochrane Database of Systematic Reviews. 2009. p. CD007113.
    1. Baschat AA, Galan HL, Bhide A, Berg C, Kush ML, Oepkes D, Thilaganathan B, Gembruch U, Harman CR. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol. 2006;27:41–47. doi: 10.1002/uog.2657.
    1. Cho CH. [The identification of high-risk pregnancy, using a simplified antepartum risk-scoring system] Taehan Kanho. 1991;30:49–65.
    1. Mikulandra F, Merlak I, Perisa M, Konjevoda M, Glavadanovic N. [Scoring of risk factors in pregnancy, labor and in the early neonatal period] Jugosl Ginekol Perinatol. 1986;26:15–21.
    1. Morrison I, Carter L, McNamara S, Cheang M. A simplified intrapartum numerical scoring system. The prediction of high risk in labor. Am J Obstet Gynecol. 1980;138:175–180.
    1. Gomez LM, De la Vega G, Padilla L, Bautista F, Villar A. Compliance with a fetal movement chart by high-risk obstetric patients in a Peruvian hospital. Am J Perinatol. 2007;24:89–93. doi: 10.1055/s-2006-958160.
    1. van Dyk B, Motto JA, Buchmann EJ. Routine second-trimester ultrasound for low risk pregnancies in a South African community. Int J Gynaecol Obstet. 2007;98:257–258. doi: 10.1016/j.ijgo.2007.03.034.
    1. Cristina MP, Ana G, Ines T, Manuel GE, Enrique IG. Perinatal results following the prenatal ultrasound diagnosis of single umbilical artery. Acta Obstet Gynecol Scand. 2005;84:1068–1074. doi: 10.1111/j.0001-6349.2005.00884.x.
    1. Sylvan K, Ryding EL, Rydhstroem H. Routine ultrasound screening in the third trimester: a population-based study. Acta Obstet Gynecol Scand. 2005;84:1154–1158. doi: 10.1111/j.0001-6349.2005.00649.x.
    1. Viero S, Chaddha V, Alkazaleh F, Simchen MJ, Malik A, Kelly E, Windrim R, Kingdom JC. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta. 2004;25:735–741. doi: 10.1016/j.placenta.2004.03.002.
    1. A randomised controlled trial of Doppler ultrasound velocimetry of the umbilical artery in low risk pregnancies. Doppler French Study Group. Br J Obstet Gynaecol. 1997;104:419–424.
    1. Davies JA, Gallivan S, Spencer JA. Randomised controlled trial of Doppler ultrasound screening of placental perfusion during pregnancy. Lancet. 1992;340:1299–1303. doi: 10.1016/0140-6736(92)92490-7.
    1. Whittle MJ, Hanretty KP, Primrose MH, Neilson JP. Screening for the compromised fetus: a randomized trial of umbilical artery velocimetry in unselected pregnancies. Am J Obstet Gynecol. 1994;170:555–559.
    1. Bancroft K, Tuffnell DJ, Mason GC, Rogerson LJ, Mansfield M. A randomised controlled pilot study of the management of gestational impaired glucose tolerance. BJOG. 2000;107:959–963. doi: 10.1111/j.1471-0528.2000.tb10396.x.
    1. Karmon A, Levy A, Holcberg G, Wiznitzer A, Mazor M, Sheiner E. Decreased perinatal mortality among women with diet-controlled gestational diabetes mellitus. Int J Gynaecol Obstet. 2009;104:199–202. doi: 10.1016/j.ijgo.2008.09.016.
    1. Fadel HE, Hammond SD. Diabetes mellitus and pregnancy: management and results. J Reprod Med. 1982;27:56–66.
    1. Nachum Z, Ben-Shlomo I, Weiner E, Ben-Ami M, Shalev E. Diabetes in pregnancy: efficacy and cost of hospitalization as compared with ambulatory management – a prospective controlled study. Isr Med Assoc J. 2001;3:915–919.
    1. Petrovic O, Skunca E, Matejcic N. A simplified fetal biophysical profile. Int J Gynaecol Obstet. 1998;61:9–14. doi: 10.1016/S0020-7292(98)00009-5.
    1. Salamalekis E, Vitoratos N, Loghis C, Mortakis A, Zourlas PA. The predictive value of a nonstress test taken 24 h before delivery in high-risk pregnancies. Int J Gynaecol Obstet. 1994;45:105–107. doi: 10.1016/0020-7292(94)90116-3.
    1. Kreiser D, el-Sayed YY, Sorem KA, Chitkara U, Holbrook RH, Jr, Druzin ML. Decreased amniotic fluid index in low-risk pregnancy. J Reprod Med. 2001;46:743–746.
    1. Sherer DM, Spong CY, Minior VK, Salafia CM. Decreased amniotic fluid volume at < 32 weeks of gestation is associated with decreased fetal movements. Am J Perinatol. 1996;13:479–482. doi: 10.1055/s-2007-994431.
    1. Shoham I, Wiznitzer A, Silberstein T, Fraser D, Holcberg G, Katz M, Mazor M. Gestational diabetes complicated by hydramnios was not associated with increased risk of perinatal morbidity and mortality. Eur J Obstet Gynecol Reprod Biol. 2001;100:46–49. doi: 10.1016/S0301-2115(01)00426-2.
    1. Seelbach-Gobel B, Heupel M, Kuhnert M, Butterwegge M. The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry. Am J Obstet Gynecol. 1999;180:73–81. doi: 10.1016/S0002-9378(99)70153-5.
    1. Stiller R, von Mering R, Konig V, Huch A, Huch R. How well does reflectance pulse oximetry reflect intrapartum fetal acidosis? Am J Obstet Gynecol. 2002;186:1351–1357. doi: 10.1067/mob.2002.122411.
    1. Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database Syst Rev. 2008:CD006593.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться